EPS Bio Technology Corp. (TPEX:4183)
Taiwan · Delayed Price · Currency is TWD 13.70
-0.50 (-3.52%)
Aug 26, 2026, 11:59 AM CST
EPS Bio Technology Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 418.74 | 499.7 | 451.08 | 470.17 | 463.45 | 480.28 | |
Revenue Growth | -10.80% | 10.78% | -4.06% | 1.45% | -3.50% | 0.56% |
Cost of Revenue | 349.99 | 412.66 | 354.82 | 354.46 | 356.04 | 359.61 |
Gross Profit | 68.74 | 87.04 | 96.27 | 115.71 | 107.42 | 120.67 |
Selling, General & Admin | 59.39 | 59.04 | 59.32 | 57.41 | 57.92 | 54.13 |
Research & Development | 31.74 | 34.5 | 33.43 | 33.22 | 30.88 | 32.28 |
Operating Expenses | 91.22 | 96.14 | 90.87 | 90.79 | 91.4 | 87.61 |
Operating Income | -22.47 | -9.1 | 5.4 | 24.92 | 16.01 | 33.06 |
Interest Expense | -2.22 | -1.9 | -2.05 | -2.14 | -2.13 | -2.18 |
Interest & Investment Income | 0.68 | 0.81 | 2.75 | 2.58 | 0.22 | 0.09 |
Currency Exchange Gain (Loss) | 0.14 | 0.14 | 11.35 | 0.97 | 13.15 | -7.55 |
Other Non Operating Income (Expenses) | 16.2 | 0.37 | 0.36 | 0.39 | 0.21 | 0.11 |
EBT Excluding Unusual Items | -7.68 | -9.67 | 17.81 | 26.72 | 27.46 | 23.52 |
Gain (Loss) on Sale of Assets | - | - | - | -0.26 | - | - |
Pretax Income | -7.68 | -9.67 | 17.81 | 26.46 | 27.46 | 23.52 |
Income Tax Expense | 2.17 | -1.8 | 0.5 | 5.47 | 2.1 | 4.88 |
Net Income | -9.85 | -7.87 | 17.31 | 20.99 | 25.36 | 18.64 |
Net Income to Common | -9.85 | -7.87 | 17.31 | 20.99 | 25.36 | 18.64 |
Net Income Growth | - | - | -17.54% | -17.24% | 36.06% | -41.20% |
Shares Outstanding (Basic) | 24 | 24 | 24 | 24 | 24 | 24 |
Shares Outstanding (Diluted) | 24 | 24 | 24 | 24 | 24 | 24 |
Shares Change | -0.67% | -0.23% | -0.08% | -0.10% | 0.03% | -0.13% |
EPS (Basic) | -0.42 | -0.33 | 0.73 | 0.88 | 1.07 | 0.78 |
EPS (Diluted) | -0.42 | -0.33 | 0.73 | 0.88 | 1.06 | 0.78 |
EPS Growth | - | - | -17.36% | -16.98% | 35.90% | -41.35% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -8.29 | -21.76 | -46.24 | 45.69 | -9.96 | 20.34 |
Free Cash Flow Per Share | -0.35 | -0.91 | -1.94 | 1.91 | -0.42 | 0.85 |
Dividend Per Share | - | - | 0.670 | 0.800 | 0.980 | 0.700 |
Dividend Growth | - | - | -16.25% | -18.37% | 40.00% | -41.67% |
Gross Margin | 16.42% | 17.42% | 21.34% | 24.61% | 23.18% | 25.12% |
Operating Margin | -5.37% | -1.82% | 1.20% | 5.30% | 3.45% | 6.88% |
Profit Margin | -2.35% | -1.57% | 3.84% | 4.46% | 5.47% | 3.88% |
Free Cash Flow Margin | -1.98% | -4.35% | -10.25% | 9.72% | -2.15% | 4.23% |
EBITDA | -9.77 | 2.28 | 15.66 | 35.9 | 28.72 | 47.01 |
EBITDA Margin | -2.33% | 0.46% | 3.47% | 7.64% | 6.20% | 9.79% |
D&A For EBITDA | 12.7 | 11.38 | 10.26 | 10.98 | 12.71 | 13.96 |
EBIT | -22.47 | -9.1 | 5.4 | 24.92 | 16.01 | 33.06 |
EBIT Margin | -5.37% | -1.82% | 1.20% | 5.30% | 3.45% | 6.88% |
Effective Tax Rate | - | - | 2.80% | 20.67% | 7.64% | 20.76% |
Advertising Expenses | - | 1.59 | - | - | - | - |